Three “detransitioners”—men who underwent surgeries in pursuit of a female gender identity but later rejected that identity—filed a legal brief supporting a Florida health agency’s rule preventing Medicaid from reimbursing for transgender medical interventions.
Florida’s Agency for Health Care Administration finalized the rule in August 2022, declaring that Medicaid would not cover “puberty blockers,” hormones, “sex reassignment” surgeries, or other procedures that alter primary or secondary sex characteristics.
Read More